undamentalytics Newsletter
Sign in

Prokidney Corp. revenue

Prokidney Corp.'s revenue was $893,000 in fiscal 2025, up 1075.0% on the year before. Over the last twelve months it was $818,000.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0076893818
Growth on the year before———+>999%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Prokidney Corp. $818,000 55.2% —
Medicinova Inc $920,481 875.7% —
Shattuck Labs, Inc. $1.0m -66.6% 5.2%
Longeveron Inc. $1.2m -42.7% 10.4%
Cardiff Oncology, Inc. $508,000 -7.0% 7.2%
Dare Bioscience, Inc. $1.4m 4366.5% —

Compare with peers

Head to head: MNOV vs PROKPROK vs STTKLGVN vs PROK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Prokidney Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Prokidney Corp.